Theragene Pharmaceuticals Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 1

Theragene Pharmaceuticals General Information

Description

Provider of immunotherapy and gene therapy technologies designed to create cancer and cardiology treatments. The company's technologies increase the body's ability to recognize and fight tumor cells and its gene therapy platform utilizes adeno-associated virus technology for the treatment of cardiovascular diseases, enabling physicians to give patients a safe alternative to traditional treatments.

Contact Information

Website
www.theragenepharma.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6150 Lusk Boulevard
  • Suite B 201
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Discovery Tools (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 6150 Lusk Boulevard
  • Suite B 201
  • San Diego, CA 92121
  • United States
+1 (858)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Theragene Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series A) 13-Dec-2017 Completed Generating Revenue
2. Seed Round 11-Aug-2015 Completed Generating Revenue
1. Seed Round 13-Mar-2014 $348K $348K Completed Generating Revenue
To view Theragene Pharmaceuticals’s complete valuation and funding history, request access »

Theragene Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of immunotherapy and gene therapy technologies designed to create cancer and cardiology treatments. The company
Biotechnology
San Diego, CA

Oxford, United Kingdom
 

Maastricht, Netherlands
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Theragene Pharmaceuticals Competitors (90)

One of Theragene Pharmaceuticals’s 90 competitors is Oxford Biotherapeutics, a Private Equity-Backed company based in Oxford, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oxford Biotherapeutics Private Equity-Backed Oxford, United Kingdom
Cristal Therapeutics Venture Capital-Backed Maastricht, Netherlands
AnTolRx Venture Capital-Backed Cambridge, MA
NexImmune Formerly VC-backed Gaithersburg, MD
Qu Biologics Venture Capital-Backed Burnaby, Canada
You’re viewing 5 of 90 competitors. Get the full list »

Theragene Pharmaceuticals Patents

  • 5

    Total Documents Applications and Grants

  • Total Patents Families

  • 5

    Granted

  • Pending

  • Expiring in next 12 mo

Theragene Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20120021926-A1 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban Active 22-Jan-2009
US-8431356-B2 Fluorescence resonance energy transfer assays for sarco/endoplasmic reticulum calcium atpase and phospholamban Active 22-Jan-2009
EP-1948246-A2 Stem cell factor therapy for tissue injury Active 14-Nov-2005
EP-1948246-B1 Stem cell factor therapy for tissue injury Active 14-Nov-2005
EP-1948246-A4 Stem cell factor therapy for tissue injury Active 14-Nov-2005 A61K48/005
To view Theragene Pharmaceuticals’s complete patent history, request access »

Theragene Pharmaceuticals Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Thynk Capital Venture Capital Minority
To view Theragene Pharmaceuticals’s complete investors history, request access »

Ready to get started?

Request a free trial

Theragene Pharmaceuticals FAQs

  • When was Theragene Pharmaceuticals founded?

    Theragene Pharmaceuticals was founded in 2011.

  • Where is Theragene Pharmaceuticals headquartered?

    Theragene Pharmaceuticals is headquartered in San Diego, CA.

  • What industry is Theragene Pharmaceuticals in?

    Theragene Pharmaceuticals’s primary industry is Biotechnology.

  • Is Theragene Pharmaceuticals a private or public company?

    Theragene Pharmaceuticals is a Private company.

  • What is Theragene Pharmaceuticals’s current revenue?

    The current revenue for Theragene Pharmaceuticals is .

  • How much funding has Theragene Pharmaceuticals raised over time?

    Theragene Pharmaceuticals has raised $548K.

  • Who are Theragene Pharmaceuticals’s investors?

    Thynk Capital has invested in Theragene Pharmaceuticals.

  • Who are Theragene Pharmaceuticals’s competitors?

    Oxford Biotherapeutics, Cristal Therapeutics, AnTolRx, NexImmune, and Qu Biologics are some of the 90 competitors of Theragene Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »